← Human Trials & Peer-Reviewed Studies
DO IT Trial: vitamin D Outcomes and Interventions in Toddlers - a TARGet Kids! randomized controlled trial.
Plain-language guide to PMID 24506910 (2014): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 750 children.
Key Facts
- PMID
- 24506910
- Journal
- BMC pediatrics
- Year
- 2014
- Study type
- Randomized Controlled Trial
- Authors
- Maguire JL et al. (10 authors)
- DOI
- 10.1186/1471-2431-14-37
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
By May, a blood sample will be drawn to determine vitamin D serum levels.
Who Took Part
According to the abstract, 750 children were involved.
PubMed indexes the participants as infants and young children.
Over 4 successive winters the researchers will recruit 750 healthy children 1-5 years of age.
Parents will obtain a nasal swab from their child with each URTI, report the number of asthma exacerbations and complete symptom checklists.
How the Study Was Run
In design terms this was a randomized study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
This study is a pragmatic randomized controlled trial.
Participating physicians are part of a primary healthcare research network called TARGet Kids!.
Unscheduled physician visits for URTIs and asthma exacerbations will be recorded.
The primary analysis will be a comparison of URTI rate between study groups using a Poisson regression model.
Secondary analyses will compare vitamin D serum levels, asthma exacerbations and the frequency of specific viral agents between groups.
What Was Measured
Topics PubMed links to this paper include Asthma, Canada, Dietary Supplements, Disease Progression, Respiratory Tract Infections, Seasons and Vitamin D.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 750 children.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 2 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2014 (BMC pediatrics), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.